Im Ellie Eunkyung bought CBIO
December 15, 2025 · Form 4 insider transaction
Im Ellie Eunkyung bought 16,298 shares of Crescent Biopharma, Inc., a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
16,298
Price
N/A
Total value
N/A
InsiderIm Ellie Eunkyung
Role—
SecurityOrdinary Shares
Transaction codeA: Grant or award
Transaction dateDecember 15, 2025
Filing dateDecember 17, 2025
Shares owned after16,298
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Represents an award of Restricted Stock Units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's Ordinary Shares. The RSUs shall vest in approximately equal three-month installments through the four-year anniversary of December 15, 2025, subject to the Reporting Person remaining continuously employed by or providing services to the Issuer or its subsidiaries from December 15, 2025 through each such vesting date.